ClinOne

ClinOne

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20.5M

Overview

Founded in 2015 and based in Denver, Colorado, ClinOne operates in the digital health sector with a focus on clinical trial enablement. The company developed a platform designed to reduce the complexity of clinical trials for all stakeholders by offering a centralized solution for patient engagement, site support, and data connectivity. Its recent acquisition by uMotif, a patient data capture company, suggests a move towards creating a more comprehensive endpoint data and patient engagement suite, though its future operations are now subsumed under the uMotif brand.

Digital Health

Technology Platform

Integrated cloud-based platform for clinical trial engagement and operations, connecting patients, care partners, and sites. Features include eConsent, scheduling, reminders, education, and site tools, designed for interoperability with EDC/CTMS systems.

Funding History

3
Total raised:$20.5M
Series B$12M
Series A$7M
Seed$1.5M

Opportunities

The acquisition by uMotif creates a comprehensive suite combining patient engagement with eCOA data capture, targeting the fast-growing decentralized clinical trial market.
Regulatory push for patient-centric trials and industry demand for integrated technology stacks present significant growth potential for the combined entity.

Risk Factors

Post-acquisition integration risk, including technology merging and client retention, is a primary challenge.
The company faces intense competition from large, established clinical tech vendors and must navigate varying global adoption rates for decentralized trial models.

Competitive Landscape

ClinOne competed in a crowded market with large players like Medidata (a Dassault Systèmes company), Veeva Systems, and IQVIA, as well as numerous point-solution startups. Its differentiation was an integrated, single-platform approach. Post-acquisition, the combined uMotif-ClinOne entity competes by offering a broader end-to-end solution for patient-facing trial technologies.